Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Donepezil Protects Against Doxorubicin-Induced Chemobrain in Rats via Attenuation of Inflammation and Oxidative Stress Without Interfering With Doxorubicin Efficacy
Benjamin Ongnok, Thawatchai Khuanjing, Titikorn Chunchai, et al.
Neurotherapeutics (2021) Vol. 18, Iss. 3, pp. 2107-2125
Open Access | Times Cited: 56

Showing 1-25 of 56 citing articles:

Cognitive impairment after cancer treatment: mechanisms, clinical characterization, and management
Ben Fleming, Paul Edison, Laura Kenny
BMJ (2023), pp. e071726-e071726
Closed Access | Times Cited: 42
Endothelial dysfunction: molecular mechanisms and clinical implications
Xia Wang, Ben He
MedComm (2024) Vol. 5, Iss. 8
Open Access | Times Cited: 25
Donepezil Regulates LPS and Aβ-Stimulated Neuroinflammation through MAPK/NLRP3 Inflammasome/STAT3 Signaling
Ji‐Eun Kim, Hyun-ju Lee, Seon Kyeong Park, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 19, pp. 10637-10637
Open Access | Times Cited: 91
Senolytic treatment alleviates doxorubicin‐induced chemobrain
Vivekananda Budamagunta, Ashok Kumar, Asha Rani, et al.
Aging Cell (2024) Vol. 23, Iss. 2
Open Access | Times Cited: 9
The Interplay of Mitochondrial Dysfunction in Oral Diseases: Recent Updates in Pathogenesis and Therapeutic Implications
Al-Hassan Soliman Wadan, Mohamed Abdelsattar Ahmed, Abdelnaser Hussein Ahmed, et al.
Mitochondrion (2024) Vol. 78, pp. 101942-101942
Closed Access | Times Cited: 8
Chemobrain: A review on mechanistic insight, targets and treatments
Vanishree Rao, Rashmi Bhushan, Priyanka Kumari, et al.
Advances in cancer research (2022), pp. 29-76
Closed Access | Times Cited: 30
Phase III Randomized, Placebo-Controlled Clinical Trial of Donepezil for Treatment of Cognitive Impairment in Breast Cancer Survivors After Adjuvant Chemotherapy (WF-97116)
Stephen R. Rapp, Emily V. Dressler, W. Mark Brown, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 21, pp. 2546-2557
Closed Access | Times Cited: 7
Galangin mitigates DOX-induced cognitive impairment in rats: Implication of NOX-1/Nrf-2/HMGB1/TLR4 and TNF-α/MAPKs/RIPK/MLKL/BDNF
Sarah A. Abd El‐Aal, Mohamed Abdelrahman, Ahmed Reda, et al.
NeuroToxicology (2022) Vol. 92, pp. 77-90
Closed Access | Times Cited: 25
Chemobrain in Breast Cancer: Mechanisms, Clinical Manifestations, and Potential Interventions
Giovana R. Onzi, Nathalia D’Agustini, Solange Cristina García, et al.
Drug Safety (2022) Vol. 45, Iss. 6, pp. 601-621
Closed Access | Times Cited: 23
ExPDrug: Integration of an interpretable neural network and knowledge graph for pathway-based drug repurposing
J.S. Kim, H. J. Jang, Youngjun Park, et al.
Computers in Biology and Medicine (2025) Vol. 187, pp. 109729-109729
Closed Access
Cardiomyopathies and a brief insight into DOX-induced cardiomyopathy
Sampat Singh Tanwar, Sumeet Dwivedi, Sheema Khan, et al.
The Egyptian Heart Journal (2025) Vol. 77, Iss. 1
Open Access
The Therapeutic Potential of Antioxidants in Chemotherapy-Induced Peripheral Neuropathy: Evidence from Preclinical and Clinical Studies
Lin Zhou, Hui Yang, Jing Wang, et al.
Neurotherapeutics (2023) Vol. 20, Iss. 2, pp. 339-358
Open Access | Times Cited: 11
Microglia contribute to mammary tumor‐induced neuroinflammation in a female mouse model
Lindsay Strehle, Lauren Otto, Corena V. Grant, et al.
The FASEB Journal (2024) Vol. 38, Iss. 2
Closed Access | Times Cited: 4
Modulating Mitochondrial Dynamics Mitigates Cognitive Impairment in Rats with Myocardial Infarction
Kewarin Jinawong, Chanon Piamsiri, Nattayaporn Apaijai, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 10, pp. 1749-1760
Open Access | Times Cited: 4
Potential of Natural Phenolic Compounds against Doxorubicin-Induced Chemobrain: Biological and Molecular Mechanisms Involved
Simona Serini, Gabriella Calviello
Antioxidants (2024) Vol. 13, Iss. 4, pp. 486-486
Open Access | Times Cited: 4
Insilico and Invivo protective effect of biochanin-A mitigating doxorubicin- induced cognitive deficits and neuroinflammation: Insights to the role of p-Tau and miR-132
Sarah Hussein, Mai F. Tolba, Haidy E. Michel, et al.
NeuroToxicology (2025)
Closed Access
HDAC6 inhibition reverses long-term doxorubicin-induced cognitive dysfunction by restoring microglia homeostasis and synaptic integrity
Blake McAlpin, Rajasekaran Mahalingam, Anand Kumar Singh, et al.
Theranostics (2021) Vol. 12, Iss. 2, pp. 603-619
Open Access | Times Cited: 26
Modulation of mitochondrial dynamics rescues cognitive function in rats with ‘doxorubicin‐induced chemobrain’ via mitigation of mitochondrial dysfunction and neuroinflammation
Benjamin Ongnok, Chayodom Maneechote, Titikorn Chunchai, et al.
FEBS Journal (2022) Vol. 289, Iss. 20, pp. 6435-6455
Closed Access | Times Cited: 18
Chemotherapy-induced cognitive impairment and glia: A new take on chemobrain?
Maria Barbosa-Azevedo, Ana Dias-Carvalho, Félix Carvalho, et al.
Toxicology and Applied Pharmacology (2024) Vol. 492, pp. 117085-117085
Open Access | Times Cited: 3
Cancer treatment induces neuroinflammation and behavioral deficits in mice
Kimberly Demos-Davies, Jessica Lawrence, Allison Rogich, et al.
Frontiers in Behavioral Neuroscience (2023) Vol. 16
Open Access | Times Cited: 7
Astrocytes’ innate role in neurodegenerative disorders
Seyed-Amirabbas Ahadiat, Zeinab Hosseinian
Bulletin of the National Research Centre/Bulletin of the National Research Center (2023) Vol. 47, Iss. 1
Open Access | Times Cited: 7
Ginkgolide attenuates memory impairment and neuroinflammation by suppressing the NLRP3/caspase-1 pathway in Alzheimer’s disease
Guang-Zhi Liu, Tian-Tong Niu, Qian Yu, et al.
Aging (2023) Vol. 15, Iss. 19, pp. 10237-10252
Open Access | Times Cited: 7
Vagus nerve stimulation and acetylcholinesterase inhibitor donepezil provide cardioprotection against trastuzumab-induced cardiotoxicity in rats by attenuating mitochondrial dysfunction
Thawatchai Khuanjing, Chayodom Maneechote, Benjamin Ongnok, et al.
Biochemical Pharmacology (2023) Vol. 217, pp. 115836-115836
Closed Access | Times Cited: 7
Nicotinic and Muscarinic Acetylcholine Receptor Agonists Counteract Cognitive Impairment in a Rat Model of Doxorubicin-Induced Chemobrain via Attenuation of Multiple Programmed Cell Death Pathways
Benjamin Ongnok, Nanthip Prathumsap, Titikorn Chunchai, et al.
Molecular Neurobiology (2024)
Closed Access | Times Cited: 2
Donepezil protects against cyclophosphamide-induced premature ovarian failure in mice: A focus on proinflammatory cytokines and NLRP3/TLR-4/NF-κB interplay
Amr Zidan, Manar Elnady, Basma N. Khalifa
Toxicology and Applied Pharmacology (2024) Vol. 488, pp. 116989-116989
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top